[Form 4] Atlassian Corporation Insider Trading Activity
Rhea-AI Filing Summary
Farquhar Scott, a director and 10% owner of Atlassian Corporation (TEAM), reported multiple open-market sales of Class A common stock executed on 08/28/2025 under a Rule 10b5-1 trading plan. The filings show five separate dispositions totaling 7,665 shares at weighted-average prices ranging roughly from $173.53 to $177.59, with reported per-trade weighted-average prices noted and a final beneficial ownership of 168,630 shares held indirectly through Farquhar Investment Partnership No. 2. The Form 4 was signed by an attorney-in-fact on 08/29/2025. The report includes explicit pricing ranges for each trade and a statement that full transaction details will be provided upon request to the SEC staff, issuer, or a security holder.
Positive
- Transactions were executed under a Rule 10b5-1 trading plan, indicating pre-planned disposition and compliance procedures
- Filing discloses price ranges and offers to provide full trade details on request, supporting transparency
Negative
- Reporting person sold a total of 7,665 Class A shares on 08/28/2025, reducing beneficial ownership to 168,630 shares
- All dispositions were sales; no purchases or offsetting acquisitions are reported in this Form 4
Insights
TL;DR: Routine insider sales executed under a pre-established 10b5-1 plan; total shares sold are modest relative to large-cap norms.
The report documents five sales totaling 7,665 Class A shares on a single date, executed under a Rule 10b5-1 trading plan adopted February 12, 2025. Reported weighted-average prices per trade range from approximately $173.53 to $177.59. The filings state the shares are held indirectly via Farquhar Investment Partnership No. 2 and show beneficial ownership after the transactions as 168,630 shares. These disclosures follow standard insider-trading compliance and provide price ranges and undertakings to disclose detailed trade-level information on request.
TL;DR: Sales were pre-planned and disclosed promptly, consistent with governance best practices; no additional governance concerns stated.
The Form 4 indicates that transactions were executed pursuant to a Rule 10b5-1 plan, which supports an affirmative defense to insider trading allegations when properly adopted and followed. The filing includes specific price ranges and an undertaking to provide full trade details on request, enhancing transparency. No amendments, new grants, option exercises, or unusual derivative transactions are reported in this filing.